tiprankstipranks
Trending News
More News >

Sarah Butler Insider Profile

4 Followers
Sarah Butler, Director at Australian Clinical Labs Ltd, holds 15.00K shares in Nanosonics Limited (Ticker: NNCSF), holds 22.62K shares in Australian Clinical Labs Ltd (Ticker: AU:ACL). Most recently, Sarah Butler Bought ― shares of Nanosonics Limited on Mar 02, 2026 for an estimated value of $50.98K.
tipranks
Sarah  Butler

Sarah Butler
Australian Clinical Labs Ltd (ACL)
Director

Ranked #60,171 out of 106,487 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-6.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$65K
58.17%
41.83%
A breakdown of Sarah Butler's holdings

Insider Roles

Australian Clinical Labs Ltd
(ACL)
Director
Nanosonics Limited
(NNCSF)
Director
Roles that Sarah Butler holds in companies

Most Profitable Insider Trade

Stock:
Nanosonics Limited
(NNCSF)
Rating:Informative Buy
Date:Mar 02, 2026 - Today
Return:-5.80%
The most profitable trade made by Sarah Butler

Sarah Butler's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Australian Clinical Labs Ltd
Feb 20, 2026
Director
Informative Buy
49.98K
AU$45.69K
Nanosonics Limited
Mar 02, 2026
Director
Informative Buy
50.98K
$32.85K
List of latest transactions for each holding click on a transaction to see Sarah Butler's performance on stock

Sarah Butler insider profile FAQ

What is the percentage of profitable transactions made by Sarah Butler?
The percentage of profitable transactions made by Sarah Butler is 0%.
    What is the average return per transaction made by Sarah Butler?
    The average return per transaction made by Sarah Butler is -6.70%.
      What stocks does Sarah Butler hold?
      Sarah Butler holds: AU:ACL, NNCSF stocks.
        What was Sarah Butler’s latest transaction?
        Sarah Butler latest transaction was an Informative Buy of $50.98K.
          What was Sarah Butler's most profitable transaction?
          Sarah Butler’s most profitable transaction was an Informative Buy of NNCSF stock on March 2, 2026. The return on the trade was -5.80%.
            What is Sarah Butler's role in Australian Clinical Labs Ltd?
            Sarah Butler's role in Australian Clinical Labs Ltd is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.